English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Share :
2009 ASCO Annual Meeting
29 May - 2 Jun 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
25 Jun 2009
Views:
13774
Rating:
Save
Rate video
Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland
Study to evaluate the frequency of complete pathologic response after neo-adjuvant treatment with cisplatin chemotherapy in women with breast cancer and a BRCA1 mutation.
Categories:
Breast
Related Videos
Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced...
Dr Kevin Kalinsky - Winship Cancer Institute, Georgia, USA
4 Jul 2024
Trastuzumab deruxtecan significantly improves PFS In breast cancer patients...
Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
4 Jul 2024
Quality of life and patient satisfaction of Filipinos after breast conservation...
Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines
4 Jul 2024
Cancer advocacy and fundraising in Nigeria
Dr Zainab Shinkafi-Bagudu - Founder, Medicaid Cancer Foundation
4 Jul 2024
Clinical behaviour of breast cancer in young BRCA carriers and prognostic...
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
4 Jul 2024
Adjuvant avelumab versus control does not significantly improve DFS but does...
Prof Pier Conte - University of Padova, Padova, Italy
4 Jul 2024
Inavolisib, palbociclib, fulvestrant combo shows sustained benefit beyond...
Dr Dejan Juric - Massachusetts General Hospital, Boston, USA
4 Jul 2024
Rates of pathologic complete response after neoadjuvant datopotamab deruxtecan...
Dr Jane Lowe Meisel - Winship Canter Institute, Atlanta, USA
4 Jul 2024
HER2DX assay and survival outcomes: An individual-patient level meta-analysis...
Dr Guillermo Villacampa - Vall d'Hebron Institute of Oncology (VHIO)...
4 Jul 2024
More from
e
cancer